This metals miner gets an upgrade from UBS, which says the stock offers ‘compelling value’

Trump could still change his mind, the sources cautioned, noting that the decision wouldn’t be finalized until the president-elect makes a formal announcement.

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

The company faced increased antitrust activity during the quarter.